NEULANDLABNeuland Laboratories Ltd.
Neuland Laboratories Q2 FY27 Results: Consolidated Net Profit ₹51.62 Crore on Total Income of ₹457 Crore
- Earnings
- Active pharmaceutical ingredients
Reviewed byRachit TripathiBlacklitt Research
Neuland Laboratories (NSE: NEULANDLAB) reported consolidated total income of ₹457.15 crore and net profit of ₹51.63 crore for the quarter ended 30 Sep 2026, it said in a filing on 03 Nov 2026. Standalone total income was the same ₹457.15 crore, with standalone net profit of ₹51.13 crore.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹457.15 crore, down 11.4% YoY and 29.7% QoQ
- Net profit: ₹51.63 crore, down 46.7% YoY and 65.0% QoQ
- EPS: ₹40.24 basic and diluted, not annualised, against ₹75.49 a year earlier
- Finance costs: ₹7.31 crore, up 36.1% YoY
Standalone
The company on its own, without its subsidiaries
- Total income: ₹457.15 crore, down 11.4% YoY and 29.7% QoQ
- Net profit: ₹51.13 crore, down 47.0% YoY and 65.3% QoQ
- EPS: ₹39.85 basic and diluted, not annualised, against ₹75.18 a year earlier
- Finance costs: ₹7.31 crore, up 36.8% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 457.15 | 516.07 | -11.4% | 650.07 | -29.7% | |
| Revenue from operations | 449.66 | 514.27 | -12.6% | 641.58 | -29.9% |
| Other income | 7.50 | 1.80 | +316.5% | 8.49 | -11.7% |
| 51.63 | 96.85 | -46.7% | 147.67 | -65.0% | |
| Profit before tax | 68.98 | 129.44 | -46.7% | 197.85 | -65.1% |
| Finance costs | 7.31 | 5.37 | +36.1% | 6.97 | +4.8% |
| Depreciation | 28.77 | 22.54 | +27.6% | 26.56 | +8.3% |
| Tax expense | 17.35 | 32.58 | -46.7% | 50.17 | -65.4% |
| Net profit margin | 11.29% | 18.77% | -7.47 pp | 22.72% | -11.42 pp |
| EPS, basic (₹) | 40.24 | 75.49 | -46.7% | 115.10 | -65.0% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit fell faster than income. Consolidated total income dropped 11.4% from a year earlier, while net profit dropped 46.7%, and profit before tax fell by the same proportion. The gap sits below the revenue line: revenue from operations fell 12.6%, and the statement shows no reason for the fall in revenue from operations from the June 2026 quarter.
Other income rose to ₹7.50 crore from ₹1.80 crore a year earlier and makes up 1.6% of total income this quarter, or 10.9% of profit before tax of ₹68.98 crore. Tax of ₹17.35 crore is 25.2% of profit before tax, against ₹32.58 crore a year earlier.
Finance costs of ₹7.31 crore are 1.6% of total income, up from ₹5.37 crore a year earlier, and depreciation rose 27.6% to ₹28.77 crore.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 457.15 | 516.07 | -11.4% | 650.07 | -29.7% | |
| Revenue from operations | 449.66 | 514.27 | -12.6% | 641.58 | -29.9% |
| Other income | 7.49 | 1.80 | +316.6% | 8.49 | -11.8% |
| 51.13 | 96.46 | -47.0% | 147.36 | -65.3% | |
| Profit before tax | 68.48 | 129.04 | -46.9% | 197.54 | -65.3% |
| Finance costs | 7.31 | 5.34 | +36.8% | 6.97 | +4.8% |
| Depreciation | 28.77 | 22.54 | +27.6% | 26.56 | +8.3% |
| Tax expense | 17.35 | 32.58 | -46.7% | 50.17 | -65.4% |
| Net profit margin | 11.18% | 18.69% | -7.51 pp | 22.67% | -11.48 pp |
| EPS, basic (₹) | 39.85 | 75.18 | -47.0% | 114.86 | -65.3% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone figures track the consolidated ones closely. Total income of ₹457.15 crore is the same as the consolidated figure, and net profit of ₹51.13 crore is ₹0.50 crore below the consolidated ₹51.63 crore. Net profit fell 47.0% YoY, slightly more than consolidated net profit.
Tax expense is ₹17.35 crore, the same as the consolidated figure, and is 25.3% of standalone profit before tax.
Standalone finance costs of ₹7.31 crore rose 36.8% YoY from ₹5.34 crore. The standalone statement carries no separate segment note; segment information is given in the consolidated results.
Inference
The filing says the board approved capital expenditure of about ₹47.1 crore including GST to acquire a land parcel of about 6 acres at Domadugu Village, Sangareddy District, Telangana, funded through internal accruals, with the rationale given as future capacity expansion. The company gives no timing for capacity additions on the land and no revenue or profit impact.
The statutory auditor issued an unmodified opinion on the limited review. Two subsidiaries with total assets of ₹12.64 crore were not reviewed by their auditors, and the auditor calls them not material to the group. The filing does not say why revenue from operations fell in the quarter, which is the main gap for a reader comparing it with the June 2026 quarter.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
